EP Patent

EP2667776A2 — Systems and methods for medical use of motion imaging and capture

Assigned to Novartis AG · Expires 2013-12-04 · 12y expired

What this patent protects

A motion sensing and capture system to provide to a patient and/or healthcare provider, patient motion data and/or motion impairment data, which can be used as a diagnostic, predictive or therapeutic tool. Such method comprises the steps of: (a) selecting one or more patient moti…

USPTO Abstract

A motion sensing and capture system to provide to a patient and/or healthcare provider, patient motion data and/or motion impairment data, which can be used as a diagnostic, predictive or therapeutic tool. Such method comprises the steps of: (a) selecting one or more patient motions; (b) using a sensing and capture system to image an initial set comprising the one or more motions to provide an initial set of motion data; and (c) conveying such initial set of motion data to a patient and/or healthcare provider.

Drugs covered by this patent

Patent Metadata

Patent number
EP2667776A2
Jurisdiction
EP
Classification
—
Expires
2013-12-04
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.